Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia

Zhejiang University

Status: Enrolling

Conditions: Androgenetic Alopecia

Treatments: Drug: 5% Minoxidil; Device: non-ablative fractional 1565nm; Device: ablative fractional 2940-nm Er: YAG laser

Study type: Interventional

Funder types: Other

Identifiers

NCT06218498

20230943

Details and patient eligibility

About

Laser sources have established their potential effect in inducing hair regrowth. No study has compared the effect of ablative fractional 2940-nm erbium yttrium aluminum garnet (Er: YAG) laser and non-fractional 15650nm fractional laser in the treatment of androgenetic alopecia (AGA).

Full description

The investigators performed a prospective study between to compare the efficacy and safety of ablative fractional 2940-nm erbium yttrium aluminum garnet (Er: YAG) laser and non-fractional 15650nm fractional laser in the treatment of androgenetic alopecia (AGA). The efficacy of the two therapies was evaluated by the investigator's Global Assessment (IGA) scores and the patient's Likert satisfaction scale at week 12 and week 24. Changes in total, terminal and villous hair count, total and terminal hair diameter, and AGA grade were also recorded. Adverse events were evaluated at each follow-up.

Enrollment: 135 estimated patients

Sex: Male

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age between 18 and 65 years;；
• clinical diagnosis of AGA；
• AGA diagnosis was evaluated following Norwood Hamilton grade II-V criteria；
• no previous laser treatments for AGA in the past six months before enrollment；
• willingness to provide pictures and follow-up studies.

Exclusion criteria

• if presented with severe diseases of internal organs, eyes, or skin;
• inflammation, infection, or unhealed wounds on the skin around the site of treatment on the head;
• systematic treatment with corticosteroids or other immunosuppressants and immunomodulators in the past 3 months

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

135 participants in 3 patient groups

ablative fractional 2940-nm erbium yttrium aluminum garnet (Er: YAG) laser

Experimental group

Treatment:

Device: ablative fractional 2940-nm Er: YAG laser

non-ablative fractional 1565nm

Experimental group

Treatment:

Device: non-ablative fractional 1565nm

5% minoxidil

Active Comparator group

Treatment:

Drug: 5% Minoxidil